Table 3.

Characteristics of patients entered on D9602

	SubGroup A N=264, median follow-up = 5.2 years (0.0 – 9.9 years)	Subgroup B (embryonal histology only) n=78, median follow-up = 4.7 years (0.7 – 8.0 years)
Stage
1	252 (97%)	55 (72%)
2	8 (3%)	9 (12%)
3	0	12 (16%)
Group
I	122 (47%)	5 (6%)
IIA	62 (24%)	16 (21%)
IIB	0	12 (16%)
IIC	0	5 (6%)
III	77 (30%)	39 (51%)
Primary Site
Paratestis	108 (41%)	17 (22%)
Uterus/cervix/vagina/vulva	19 (7%)	18 (24%)
Orbit	96 (37%)	2 (3%)
Head and Neck	29 (11%)	13 (17%)
Parameningeal	0	3 (4%)
Extremity	2 (1%)	4 (5%)
Other	7 (3%)	19 (25%)
Nodal Status
N0	259 (99%)	58(76%)
N1	0	17 (22%)
Nx	1 (<1%)	1 (1%)